Muscle Strength and Inflammatory Response in Patients With Inclusion Body Myositis

Evaluation of Muscle Strength and Inflammatory Response in Patients With Inclusion Body Myositis

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT00898989

Acronym

IBMan

Enrollment

Registered

2009-05-12

Start date

2009-04-30

Completion date

2010-04-30

Last updated

2010-12-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Inclusion Body Myositis

Brief summary

Comparison of a group of 20 IBM patients with 20 controls matched on age, gender and weight.

Interventions

None listed

Study design

Observational model

CASE_CONTROL

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Yes

Inclusion criteria

* Age \> 18 years old * Written consent

Exclusion criteria

* Current infection * Cancer within 1 year * Immune deficiency

Design outcomes

Primary

Measure	Time frame
muscle strength	2 evaluations at an interval of 9 months

Secondary

Measure	Time frame
immune response	1 measure at inclusion

Countries

France

Outcome results